Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Current Value
$161.381 Year Return
Current Value
$161.381 Year Return
Market Cap
$17.99B
P/E Ratio
21.63
1Y Stock Return
19.98%
1Y Revenue Growth
2.60%
Dividend Yield
2.06%
Price to Book
2.7
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LH | 65.50% | $19.76B | +11.24% | 0.91% |
POR | 44.91% | $4.95B | +14.95% | 4.16% |
OGE | 44.15% | $8.67B | +24.45% | 3.88% |
D | 43.96% | $48.38B | +24.06% | 4.62% |
PM | 43.40% | $201.41B | +39.59% | 4.05% |
EXC | 42.88% | $39.29B | +0.57% | 3.88% |
LNT | 42.20% | $15.97B | +26.81% | 3.08% |
KMB | 41.11% | $45.22B | +11.57% | 3.58% |
AEE | 40.62% | $24.59B | +20.10% | 2.87% |
IDA | 40.52% | $6.27B | +21.37% | 2.85% |
EVRG | 40.28% | $14.71B | +27.45% | 4.01% |
PNW | 38.79% | $10.34B | +26.67% | 3.90% |
NWE | 37.95% | $3.41B | +10.00% | 4.68% |
HOLX | 37.86% | $18.25B | +9.26% | 0.00% |
HSTM | 37.37% | $980.58M | +26.38% | 0.43% |
NI | 37.37% | $17.32B | +42.68% | 2.86% |
JNJ | 36.21% | $368.37B | +1.24% | 3.18% |
AVA | 35.83% | $3.07B | +11.83% | 3.68% |
ADC | 35.80% | $8.03B | +36.00% | 3.88% |
MDLZ | 35.79% | $85.41B | -10.00% | 2.73% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
BMA | <0.01% | $5.08B | +232.03% | 6.53% |
PEGA | 0.02% | $7.36B | +65.88% | 0.14% |
MU | -0.05% | $108.36B | +27.40% | 0.47% |
ATI | 0.05% | $8.31B | +32.37% | 0.00% |
SOLV | -0.07% | $11.58B | -16.19% | 0.00% |
TXMD | -0.07% | $14.99M | -53.32% | 0.00% |
GIB.A | 0.07% | $24.72B | +8.31% | 0.00% |
NET | 0.08% | $33.09B | +30.49% | 0.00% |
S | -0.09% | $8.76B | +59.38% | 0.00% |
HPE | 0.11% | $27.96B | +37.84% | 2.42% |
PENG | -0.13% | $911.79M | +4.97% | 0.00% |
WDFC | -0.14% | $3.79B | +20.32% | 1.26% |
BEST | 0.15% | $31.65M | +3.88% | 0.00% |
IRTC | 0.15% | $2.36B | -9.35% | 0.00% |
OLED | 0.17% | $7.80B | +0.63% | 0.95% |
MELI | 0.20% | $97.16B | +28.15% | 0.00% |
SKYW | -0.21% | $4.43B | +136.32% | 0.00% |
UPWK | -0.23% | $2.00B | +9.38% | 0.00% |
BILL | -0.24% | $8.91B | +36.98% | 0.00% |
ARQT | -0.24% | $1.18B | +433.86% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
PSTG | -19.13% | $16.35B | +36.41% | 0.00% |
HUSA | -17.74% | $16.69M | -11.56% | 0.00% |
FROG | -15.95% | $3.34B | +11.67% | 0.00% |
CAMT | -14.41% | $3.40B | +16.39% | 0.00% |
NVDA | -14.29% | $3.61T | +194.35% | 0.07% |
RBRK | -13.38% | $8.03B | +38.16% | 0.00% |
CFLT | -13.11% | $9.28B | +49.05% | 0.00% |
DDOG | -12.52% | $45.32B | +19.19% | 0.00% |
VRT | -12.32% | $52.90B | +230.61% | 0.07% |
NTNX | -11.69% | $18.33B | +70.72% | 0.00% |
ABEO | -11.24% | $256.04M | +41.25% | 0.00% |
SCKT | -11.20% | $10.88M | +15.32% | 0.00% |
SRRK | -11.17% | $2.61B | +134.91% | 0.00% |
ANET | -11.06% | $118.95B | +75.41% | 0.00% |
SMCI | -10.97% | $16.55B | -2.47% | 0.00% |
CRWD | -10.96% | $86.61B | +69.05% | 0.00% |
VIST | -10.93% | $4.75B | +67.10% | 0.00% |
BOOM | -10.89% | $151.20M | -52.25% | 0.00% |
SLE | -10.53% | $8.82M | -63.18% | 0.00% |
AVGO | -10.49% | $772.28B | +68.52% | 9.87% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SPLV | 51.73% | $8.93B | 0.25% |
FXH | 50.38% | $1.15B | 0.62% |
SPHD | 48.01% | $3.46B | 0.3% |
RSPH | 47.03% | $885.96M | 0.4% |
LVHD | 46.67% | $560.70M | 0.27% |
IYK | 46.06% | $1.30B | 0.4% |
FVD | 45.59% | $9.70B | 0.6% |
CDC | 44.50% | $821.08M | 0.38% |
SDY | 44.06% | $21.19B | 0.35% |
HDV | 43.87% | $11.19B | 0.08% |
FSTA | 43.75% | $1.20B | 0.084% |
VDC | 43.15% | $7.09B | 0.1% |
KXI | 42.87% | $695.03M | 0.41% |
KNG | 42.73% | $3.53B | 0.75% |
LGLV | 42.44% | $811.95M | 0.12% |
XLP | 42.03% | $16.03B | 0.09% |
NOBL | 41.81% | $12.44B | 0.35% |
SMMV | 41.75% | $321.07M | 0.2% |
VOE | 41.74% | $18.25B | 0.07% |
VOOV | 41.36% | $5.36B | 0.1% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHLF | -0.08% | $874.27M | 0.03% |
GSG | -0.08% | $914.42M | 0.75% |
FTXL | 0.13% | $1.31B | 0.6% |
BTAL | -0.14% | $388.04M | 1.43% |
DBMF | -0.15% | $1.02B | 0.85% |
PNQI | -0.27% | $834.26M | 0.6% |
XLG | 0.30% | $7.40B | 0.2% |
JEPQ | 0.34% | $18.60B | 0.35% |
ICLO | 0.38% | $209.30M | 0.2% |
QQQ | -0.40% | $317.87B | 0.2% |
JUCY | 0.42% | $324.29M | 0.6% |
QQQM | -0.44% | $36.44B | 0.15% |
TAIL | -0.48% | $67.98M | 0.59% |
ONEQ | 0.50% | $7.14B | 0.21% |
FDN | -0.52% | $6.98B | 0.51% |
IUSG | -0.60% | $20.37B | 0.04% |
COMT | -0.67% | $829.06M | 0.48% |
SFYF | 0.69% | $19.96M | 0.29% |
TMFC | -0.75% | $1.13B | 0.5% |
ILCG | -0.86% | $2.44B | 0.04% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
HIGH | -15.38% | $302.78M | 0.51% |
IBTE | -14.33% | $1.70B | 0.07% |
VIXY | -14.27% | $195.31M | 0.85% |
USDU | -13.50% | $201.97M | 0.5% |
EQLS | -12.46% | $76.08M | 1% |
HDRO | -11.88% | $164.26M | 0.3% |
UUP | -9.48% | $309.25M | 0.77% |
DBE | -9.41% | $50.13M | 0.77% |
KCCA | -9.37% | $220.51M | 0.87% |
DBO | -8.82% | $217.57M | 0.77% |
AGZD | -7.75% | $142.76M | 0.23% |
TPMN | -7.24% | $40.60M | 0.65% |
CTA | -7.00% | $350.27M | 0.78% |
KRBN | -6.80% | $242.47M | 0.85% |
PWZ | -6.77% | $697.36M | 0.28% |
FMF | -6.70% | $244.61M | 0.95% |
KMLM | -6.63% | $353.87M | 0.9% |
ICSH | -6.41% | $5.57B | 0.08% |
SGOV | -6.19% | $27.53B | 0.09% |
DBA | -6.10% | $755.88M | 0.93% |
SeekingAlpha
We are concerned about todayâs high valuations and stretched valuations. Are these all a grand illusion? Click here to find out.
Yahoo
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score.
MarketWatch
Quest Diagnostics Inc. stock outperforms competitors on strong trading day
Yahoo
Stryker launches the next generation of SurgiCount+ to boost sponge management and blood loss assessment in hospitals.
Yahoo
Quest Diagnostics' (NYSE:DGX) stock is up by a considerable 5.0% over the past month. As most would know, fundamentals...
MarketWatch
Quest Diagnostics Inc. stock underperforms Thursday when compared to competitors
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.